FSD PHARMA INC-CLASS B (HUGE)
CA35954B4047 - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -33.94M | -28.45M | -38.96M | -17.01M | -2.64M | |||
| Depreciation Amortization | 4.05M | 3.90M | 2.36M | 137.21K | N/A | |||
| Change In Working Capital | 2.89M | 807.14K | -1.38M | -247.26K | 287.66K | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 6.26M | 4.61M | 24.33M | 3.27M | 2.24M | |||
| OPERATING CASH FLOW | -20.75M | -19.13M | -13.65M | -13.85M | -112.25K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -500.00K | 0.00 | -691.90K | -3.02M | -5.73M | |||
| Other Investing Activity | 768.96K | 6.51M | 462.02K | -4.46M | N/A | |||
| INVESTING CASH FLOW | 268.96K | 6.51M | -229.88K | -7.48M | -5.73M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -129.33K | -986.64K | -42.10K | N/A | N/A | |||
| Stock Issued/Repurchased | 38.34M | 25.16M | 4.06M | 36.44M | 10.33M | |||
| Other Financing Activity | 0.00 | N/A | -24.50K | -2.82M | -952.72K | |||
| FINANCING CASH FLOW | 38.21M | 24.17M | 3.99M | 33.61M | 9.37M | |||
| CHANGE IN CASH | 17.73M | 11.56M | -9.89M | 12.28M | 3.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.75M | -19.13M | -13.65M | -13.85M | -112.25K | |||
| Capital Expenditure | -500.00K | 0.00 | -691.90K | -3.02M | -5.73M | |||
| FREE CASH FLOW | -21.25M | -19.13M | -14.34M | -16.87M | -5.84M | |||
All data in USD